logo
InterimDataFromTwoOngoingInvestigator-initiatedTrialsHighlighttheRoleofSculptraandRestylaneinAddressingAestheticChangesAssociatedWithWeightLossMedicationsandMenopause
===2026/4/9 14:11:32===
U.S. Food and Drug Administration. Sculptra summary of safety and effectiveness data. Availableonline. Accessed April 2026.

Zhang Y, et al. In vivo inducing collagen regeneration of biodegradable polymer microspheres. Regen Biomater. 2021;8(5):rbab042. doi: 10.1093/rb/rbab042.

Waibel J, et al. A randomized, comparative study describing the gene signatures of poly-L-lactic acid (PLLA-SCA) and calcium hydroxylapaptite (CaHA) in the treatment of nasolabial folds. Poster presented at IMCAS World Congress; February 3-6. 2024; Paris, France.

Huth S, et al. Molecular insights into the effects of PLLA-SCA on gene expression and collagen synthesis in human 3d skin models containing macrophages. J Drugs Dermatol. 2024;23(4):285-288. doi: 10.36849/JDD.7791.

Zubair R, et al. SPLASH: Split-body randomized clinical trial of poly-L-lactic acid for adipogenesis and volumization of the hip dell. Dermatol Surg. 2024;50(12):1155-1162. doi: 10.1097/DSS.00000
=*=*=*=*=*=
当前为第11/13页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页